New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 19, 2013
10:45 EDTTSRO, TSRO, OPK, OPKSummer Street's chief scientific officer holds analyst/industry conference call
Chief Scientific Officer Classen discusses OPKO Health (OPK) and Tesaro's (TSRO) Rolapitant, for the treatment of chemotherapy-induced nausea and vomiting, on an Analyst/Industry conference call to be held on December 19 at 11 am.
News For OPK;TSRO From The Last 14 Days
Check below for free stories on OPK;TSRO the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 17, 2014
11:24 EDTOPKOPKO Health to acquire Inspiro Medical, terms not disclosed
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use